Moreover, reduced tumor infiltration of CD4+ T cells caused by ROS burst might also impair immunotherapy targeting liver tumors, suggesting that overcoming FA-induced impairment could be a potential strategy for obesity-related HCC (115). Here, CD4 is linked to hepatocellular carcinoma.